Location of Repository

Metabolic syndrome and risk factors for non-alcoholic fatty liver disease

By Mônica Rodrigues de Araújo Souza, Margareth de Fátima Formiga de Melo Diniz, José Eymard Moraes de Medeiros-Filho and Maria Salete Trigueiro de Araújo

Abstract

CONTEXT: Non-alcoholic fatty liver disease (NAFLD), hepatic manifestation of metabolic syndrome, has been considered the most common liver disease nowadays, which is also the most frequent cause of elevated transaminases and cryptogenic cirrhosis. The greatest input of fatty acids into the liver and consequent increased beta-oxidation contribute to the formation of free radicals, release of inflammatory cytokines and varying degrees of hepatocytic aggression, whose histological expression may vary from steatosis (HS) to non-alcoholic steatohepatitis (NASH). The differentiation of these forms is required by the potential risk of progression to cirrhosis and development of hepatocellular carcinoma. OBJECTIVE: To review the literature about the major risk factors for NAFLD in the context of metabolic syndrome, focusing on underlying mechanisms and prevention. METHOD: PubMed, MEDLINE and SciELO data basis analysis was performed to identify studies describing the link between risk factors for metabolic syndrome and NAFLD. A combination of descriptors was used, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and risk factors. At the end, 96 clinical and experimental studies, cohorts, meta-analysis and systematic reviews of great impact and scientific relevance to the topic, were selected. RESULTS: The final analysis of all these data, pointed out the central obesity, type 2 diabetes, dyslipidemia and hypertension as the best risk factors related to NAFLD. However, other factors were highlighted, such as gender differences, ethnicity, genetic factors and the role of innate immunity system. How these additional factors may be involved in the installation, progression and disease prognosis is discussed. CONCLUSION: Risk factors for NAFLD in the context of metabolic syndrome expands the prospects to 1) recognize patients with metabolic syndrome at high risk for NAFLD, 2) elucidate pathways common to other co-morbidities, 3) determine risk factors associated with a worse prognosis, 4) develop therapeutic strategies with goal of reducing risk factors, 5) apply acquired knowledge in public health policies focusing on preventive strategies

Topics: Síndrome X metabólica, Fígado gorduroso não-alcoólico, Fatores de risco, Diseases of the digestive system. Gastroenterology, RC799-869, Specialties of internal medicine, RC581-951, Internal medicine, RC31-1245, Medicine, R
Publisher: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia (IBEPEGE)
Year: 2012
DOI identifier: 10.1590/S0004-28032012000100015
OAI identifier: oai:doaj.org/article:5814098b614b439aa722863790fe716d
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • https://doaj.org/toc/1678-4219 (external link)
  • http://www.scielo.br/scielo.ph... (external link)
  • https://doaj.org/article/58140... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.